Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |